Nalaganje...
Androgen Receptor-Induced Integrin α6β1 and Bnip3 Promotes Survival and Resistance to PI3K Inhibitors in Castration-Resistant Prostate Cancer
The androgen receptor (AR) is the major driver of prostate cancer growth and survival. However, almost all patients relapse with castration resistant disease (CRPC) when treated with anti-androgen therapy. In CRPC, AR is often aberrantly activated independent of androgen. Targeting survival pathways...
Shranjeno v:
| izdano v: | Oncogene |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395876/ https://ncbi.nlm.nih.gov/pubmed/32565538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-1370-9 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|